Abstract:Background Previous studies have identified COVID-19 risk factors, such as age and chronic health conditions, linked to severe outcomes and mortality. However, accurately predicting severe illness in COVID-19 patients remains challenging, lacking precise methods. Objective This study aimed to leverage clinical real-world data and multiple machine-learning algorithms to formulate innovative predictive models for assessing the risk of severe outcomes or mortality in hospitalized patients with COVID-19. Methods Data were obtained from the Taipei Medical University Clinical Research Database (TMUCRD) including electronic health records from three Taiwanese hospitals in Taiwan. This study included patients admitted to the hospitals who received an initial diagnosis of COVID-19 between January 1, 2021, and May 31, 2022. The primary outcome was defined as the composite of severe infection, including ventilator use, intubation, ICU admission, and mortality. Secondary outcomes consisted of individual indicators. The dataset encompassed demographic data, health status, COVID-19 specifics, comorbidities, medications, and laboratory results. Two modes (full mode and simplified mode) are used; the former includes all features, and the latter only includes the 30 most important features selected based on the algorithm used by the best model in full mode. Seven machine learning was employed algorithms the performance of the models was evaluated using metrics such as the area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, and specificity. Results The study encompassed 22,192 eligible in-patients diagnosed with COVID-19. In the full mode, the model using the light gradient boosting machine algorithm achieved the highest AUROC value (0.939), with an accuracy of 85.5%, a sensitivity of 0.897, and a specificity of 0.853. Age, vaccination status, neutrophil count, sodium levels, and platelet count were significant features. In the simplified mode, the extreme gradient boosting algorithm yielded an AUROC of 0.935, an accuracy of 89.9%, a sensitivity of 0.843, and a specificity of 0.902. Conclusion This study illustrates the feasibility of constructing precise predictive models for severe outcomes or mortality in COVID-19 patients by leveraging significant predictors and advanced machine learning. These findings can aid healthcare practitioners in proactively predicting and monitoring severe outcomes or mortality among hospitalized COVID-19 patients, improving treatment and resource allocation.

Genetic justification of COVID‐19 patient outcomes using DERGA, a novel data ensemble refinement greedy algorithm

Prognosis of COVID-19 severity using DERGA, a novel machine learning algorithm

Revealing the nature of cardiovascular disease using DERGA, a novel data ensemble refinement greedy algorithm

LGALS9, LAMP3, PRSS8 and AGRN Predict Hospitalisation Risk in COVID-19 Patients

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Identification of Risk Factors for Mortality Associated with COVID-19

Peer Review #1 of "identification of Risk Factors for Mortality Associated with COVID-19 (V0.1)"

Whole-genome sequencing reveals host factors underlying critical COVID-19

A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province, China

Genetic Determinants of COVID-19 Drug Efficacy Revealed by Genome-Wide CRISPR Screens

Potential Plasma Proteins (LGALS9, LAMP3, PRSS8 and AGRN) as Predictors of Hospitalisation Risk in COVID-19 Patients

An AI-powered patient triage platform for future viral outbreaks using COVID-19 as a disease model

Delineating COVID-19 subgroups using routine clinical data identifies distinct in-hospital outcomes

Identification and Validation of Prognostic Factors in Patients with COVID-19: A Retrospective Study Based on Artificial Intelligence Algorithms

The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses

Genetic mechanisms of critical illness in Covid-19

Predicting Patient COVID-19 Disease Severity by means of Statistical and Machine Learning Analysis of Blood Cell Transcriptome Data

Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

Unveiling the future of COVID-19 patient care: groundbreaking prediction models for severe outcomes or mortality in hospitalized cases